Fresh controversies are heating up over the marketing of products to prevent cervical cancer The U.S. Food & Drug Administration is gearing up to make critical decisions about two controversial vaccines. On Sept. 9 an FDA advisory committee will consider whether Merck … [Read more...] about Is Merck Overselling a Cancer Vaccine?
Archives for September 2009
Merck’s Back-to-School Special…
...Push Gardasil to achieve greater vaccination rates Less then a month after a JAMA article critized Merck for aggressively marking Gardasil, Merck is planning a big-time advertising push on Gardasil, hoping to revive flagging sales of the human papillomavirus vaccine. As … [Read more...] about Merck’s Back-to-School Special…
BioSante Pharmaceuticals’ BioVantTM Adjuvanted Vaccine Reports 100% Protection From H1N1 Virus
BioSante's vaccine adjuvant, BioVantTM, increases the protective effect of vaccines for multiple flu strains BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) announced today's presentation of H1N1 vaccine results at the Immunotherapeutics & Vaccine Summit in Providence, RI. … [Read more...] about BioSante Pharmaceuticals’ BioVantTM Adjuvanted Vaccine Reports 100% Protection From H1N1 Virus